MARKET

CELG-RT

CELG-RT

Bristol-Myers Squibb Company Celegne Contingent Value Rights
NYSE
0.0400
0.0000
0.00%
Closed 09:30 05/02 EDT
OPEN
0.0400
PREV CLOSE
0.0400
HIGH
0.0400
LOW
0.0400
VOLUME
105
TURNOVER
17
52 WEEK HIGH
0.1550
52 WEEK LOW
0.0150
MARKET CAP
28.46M
P/E (TTM)
0.0150
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CELG RT last week (0428-0502)?
Weekly Report · 3h ago
Weekly Report: what happened at CELG RT last week (0421-0425)?
Weekly Report · 04/28 09:15
Weekly Report: what happened at CELG RT last week (0414-0418)?
Weekly Report · 04/21 09:15
Weekly Report: what happened at CELG RT last week (0407-0411)?
Weekly Report · 04/14 09:13
Weekly Report: what happened at CELG RT last week (0331-0404)?
Weekly Report · 04/07 09:13
Weekly Report: what happened at CELG RT last week (0324-0328)?
Weekly Report · 03/31 09:15
Weekly Report: what happened at CELG RT last week (0317-0321)?
Weekly Report · 03/24 09:13
Weekly Report: what happened at CELG RT last week (0310-0314)?
Weekly Report · 03/17 09:14
More
About CELG-RT
More
Bristol-Myers Squibb Company is a global biopharmaceutical company. It is engaged in the discovery, development and delivery of transformational medicines for patients facing serious diseases in areas: oncology, hematology, immunology, cardiovascular, neuroscience and other areas. Its platforms comprise chemically synthesized or small molecule drugs, including protein degraders; drugs produced from biological processes, called biologics; ADCs, CAR-T cell therapies, and radiopharmaceutical therapeutics. Small molecule drugs are typically administered orally in the form of a tablet or capsule, although other drug delivery mechanisms are also used. Biologics are typically administered through injections or by intravenous infusion. CAR-T cell therapies are administered by intravenous infusion. Its growth portfolio includes Opdivo, Opdivo Qvantig, Orencia, Yervoy, Reblozyl, Opdualag, and others. Its legacy portfolio includes Eliquis, Revlimid, Pomalyst/Imnovid, Sprycel and Abraxane.
Recently
Symbol
Price
%Change

Webull offers Bristol-Myers Squibb Co stock information, including NYSE: CELG RT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CELG RT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CELG-RT stock methods without spending real money on the virtual paper trading platform.